{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T15:00:20Z","timestamp":1786460420659,"version":"build-2736575974"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>The aim of this scoping review is to map the existing information on the characteristics of the use of complementary and alternative medicine (CAM) as treatment for the signs and symptoms of autism spectrum disorder (ASD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>ASD is a neurodevelopmental disorder marked by social-communication difficulties and restrictive, repetitive behaviors resulting from complex interactions of genetic and environmental factors, and associated with psychological and medical comorbidities. It is a global phenomenon with a detrimental impact on families. Supplemental to conventional treatments, caregivers can consider using CAM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Eligibility criteria:<\/jats:title>\n                    <jats:p>Primary, secondary, and gray literature sources considering the use of CAM for treating the signs and symptoms of ASD in participants of any age will be included. Sources proposing the use of CAM for any condition other than ASD or discussing any therapy for ASD other than CAM will be excluded. Studies in all languages will be considered for inclusion, as will sources from the past decade.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This scoping review will be conducted in line with the JBI scoping review framework and reported using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews. A primary search of PubMed to identify keywords and phrases will be followed by subsequent searches of Emcare (Ovid), Nursing and Allied Health Premium (ProQuest), Scopus, and Google Scholar. The titles, abstracts, and full texts of identified sources will be screened for relevancy by 2 reviewers independently, with conflicts adjudicated by a third reviewer. Findings will be discussed in a narrative summary and illustrated using figures, tables, and a gap map.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Review registration:<\/jats:title>\n                    <jats:p>OSF https:\/\/osf.io\/c9j5n\/overview<\/jats:p>\n                  <\/jats:sec>","DOI":"10.11124\/jbies-25-00264","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T09:00:15Z","timestamp":1770109215000},"page":"806-813","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Global characteristics of the use of complementary and alternative medicine for autism spectrum disorder: a scoping review protocol"],"prefix":"10.11124","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-1883-4073","authenticated-orcid":false,"given":"Georgia Mae","family":"Willcox","sequence":"first","affiliation":[{"name":"Department of Anatomical Sciences, School of Biomedical Sciences, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, Gauteng, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6789-055X","authenticated-orcid":false,"given":"Dorothy Agnes","family":"Shead","sequence":"additional","affiliation":[{"name":"Department of Anatomical Sciences, School of Biomedical Sciences, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, Gauteng, South Africa"},{"name":"Department of Physiotherapy, School of Therapeutic Sciences, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, Gauteng, South Africa,"},{"name":"JBI Centre for Evidenced-Based Practice University of the Witwatersrand, Johannesburg, Gauteng, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5859-3844","authenticated-orcid":false,"given":"Busisiwe Constance","family":"Maseko","sequence":"additional","affiliation":[{"name":"Department of Anatomical Sciences, School of Biomedical Sciences, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, Gauteng, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"issue":"12","key":"R1-20260527","first-page":"972-9","article-title":"Autism spectrum disorder: primary care principles","volume":"94","author":"Sanchack","year":"2016","journal-title":"Am Fam Physician"},{"issue":"5","key":"R2-20260527","doi-asserted-by":"crossref","first-page":"778-90","DOI":"10.1002\/aur.2696","article-title":"Global prevalence of autism: a systematic review update","volume":"15","author":"Zeidan","year":"2022","journal-title":"Autism Res"},{"key":"R3-20260527","first-page":"407-18","article-title":"Autism and related disorders","volume":"106","author":"McPartland","year":"2012","journal-title":"Handb Clin Neurol"},{"issue":"1","key":"R4-20260527","first-page":"68-79","article-title":"Theoretical aspects of autism: causes\u2014a review","volume":"8","author":"Ratajczak","year":"2011","journal-title":"J Immunotoxicol"},{"issue":"2","key":"R5-20260527","doi-asserted-by":"crossref","first-page":"1-22","DOI":"10.15585\/mmwr.ss7402a1","article-title":"Prevalence and early identification of autism spectrum disorder among children aged 4 and 8 years \u2014 Autism and Developmental Disabilities Monitoring Network, 16 sites, United States, 2022","volume":"74","author":"Shaw","year":"2025","journal-title":"MMWR Surveill Summ"},{"issue":"4","key":"R6-20260527","doi-asserted-by":"crossref","first-page":"295-9","DOI":"10.1017\/S1092852916000262","article-title":"Neurodevelopmental disorders (ASD and ADHD): DSM-5, ICD-10, and ICD-11","volume":"21","author":"Doernberg","year":"2016","journal-title":"CNS Spectr"},{"issue":"9920","key":"R7-20260527","doi-asserted-by":"crossref","first-page":"896-910","DOI":"10.1016\/S0140-6736(13)61539-1","article-title":"Autism","volume":"383","author":"Lai","year":"2014","journal-title":"Lancet"},{"issue":"6","key":"R8-20260527","doi-asserted-by":"crossref","first-page":"983-1006","DOI":"10.1016\/j.pcl.2007.09.006","article-title":"Complementary and alternative medical therapies for attention-deficit\/hyperactivity disorder and autism","volume":"54","author":"Weber","year":"2007","journal-title":"Pediatr Clin North Am"},{"key":"R9-20260527","doi-asserted-by":"crossref","first-page":"91-104","DOI":"10.1016\/j.pharmthera.2018.05.007","article-title":"Autism spectrum disorder: classification, diagnosis and therapy","volume":"190","author":"Sharma","year":"2018","journal-title":"Pharmacol Ther"},{"issue":"2","key":"R10-20260527","doi-asserted-by":"crossref","first-page":"469-94","DOI":"10.1016\/j.chc.2022.08.004","article-title":"Autism spectrum disorder and complementary-integrative medicine","volume":"32","author":"Vandana","year":"2023","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"issue":"1","key":"R11-20260527","first-page":"870391","article-title":"A review of complementary and alternative treatments for autism spectrum disorders","volume":"2012","author":"Lofthouse","year":"2012","journal-title":"Autism Res Treat"},{"key":"R12-20260527","first-page":"1-11","article-title":"Complementary and alternative medicine for autism - a systematic review","author":"Doherty","journal-title":"J Autism Dev Disord"},{"issue":"4","key":"R13-20260527","first-page":"369-74","article-title":"Complementary and alternative treatments for autism part 1: evidence-supported treatments","volume":"17","author":"Bent","year":"2015","journal-title":"AMA J Ethics"},{"issue":"7","key":"R14-20260527","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.11124\/JBIES-23-00247","article-title":"Global pharmaceutical care approaches to autism spectrum disorder: a scoping review protocol","volume":"22","author":"Sape","year":"2024","journal-title":"JBI Evid Synth"},{"issue":"9","key":"R15-20260527","doi-asserted-by":"crossref","first-page":"E438","DOI":"10.1111\/jpc.12242","article-title":"Complementary and alternative medicine for autism spectrum disorders: Rationale, safety and efficacy","volume":"49","author":"Whitehouse","year":"2013","journal-title":"J Paediatr Child Health"},{"issue":"4","key":"R16-20260527","first-page":"375-80","article-title":"Complementary and alternative treatments for autism part 2: identifying and avoiding non-evidence-based treatments","volume":"17","author":"Singer","year":"2015","journal-title":"AMA J Ethics"},{"issue":"3","key":"R17-20260527","doi-asserted-by":"crossref","first-page":"393-7","DOI":"10.1016\/j.pedhc.2016.12.001","article-title":"Complementary and alternative medicine in the school-age child with autism","volume":"31","author":"Nath","year":"2017","journal-title":"J Pediatr Health Care"},{"issue":"7","key":"R18-20260527","doi-asserted-by":"crossref","first-page":"467-73","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for Scoping Reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med"},{"issue":"1","key":"R19-20260527","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12874-018-0611-x","article-title":"Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach","volume":"18","author":"Munn","year":"2018","journal-title":"BMC Med Res Methodol"},{"key":"R20-20260527","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"1","key":"R21-20260527","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/XEB.0000000000000152","article-title":"The development of software to support multiple systematic review types: the Joanna Briggs Institute System for the Unified Management, Assessment and Review of Information (JBI SUMARI)","volume":"17","author":"Munn","year":"2019","journal-title":"Int J Evid Based Healthc"}],"container-title":["JBI Evidence Synthesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.11124\/JBIES-25-00264","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T12:50:51Z","timestamp":1786452651000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.11124\/JBIES-25-00264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,3]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.11124\/jbies-25-00264","relation":{},"ISSN":["2689-8381"],"issn-type":[{"value":"2689-8381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,3]]}}}